News and MEdia

UPMC implemented a new technology in partnership with RxRevu, to enable its physicians to help patients lower prescription drug costs based upon their insurance coverage.

In the first five months of 2020, RxRevu hit a number of key milestones in the success of their SwiftRx Direct solution.

This week, 35+ companies stepped up efforts to prevent the spread of COVID-19 here in Colorado and beyond.

RxRevu achieved unprecedented growth in 2019, advancing its position as the leader in Prescription Decision Support. In only eight months, use of RxRevu’s integrated prescription cost transparency solution, SwiftRx® Direct™, grew from less than ten health systems, to more than 320 health systems across the country.

Terri Huffstetler needed an IV drug in the emergency room to treat a blood clot. The 58-year-old Thrall, TX, woman knew her hospital was in her insurance plan’s network, yet she was shocked to receive a bill for $1,437.62 from E-Merge Physicians.

RxRevu has reached an agreement with Cerner Corporation (Nasdaq: CERN) to integrate its pharmacy and patient prescription pricing solution into the electronic health record (EHR) to help providers choose the most cost-effective medication for patients.

RxRevu, the nation’s only independent provider of integrated prescription cost transparency solutions, announced today it has entered into an agreement with Epic, the leading provider of electronic health record (EHR) software.

What started as a book of pharmaceuticals organized by efficacy and cost has been built into a Denver startup that has recently raised $15.9 million through its partnership with UCHealth.

The funding will fuel RxRevu’s continued growth as the only independent provider of EHR-integrated tools that assist clinicians in prescribing the right medication at the lowest patient cost possible.